SlideShare a Scribd company logo
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5
Time, min
0.0
1000.0
2000.0
3000.0
4000.0
5000.0
6000.0
7000.0
8000.0
9000.0
1.0e4
1.1e4
1.2e4
1.3e4
1.4e4
1.5e4
1.6e4
Intensity,cps
Dihydrostreptomycin
Streptomycin
● Instrument : AB Sciex 3200 QQQ.
● ESI Parameters: TEM = 400, IS = 3000, compound specific parameters in Table 1.
● Injection volume = 30 µL.
● HPLC Columns:
● Column 1: Ascentis Express HILIC (100 × 2.1mm, 2.7µm particle size).
● Column 2: SeQuant ZIC-pHILIC (150 × 2.1mm, 5µm particle size).
● Column 3: SeQuant ZIC-cHILIC (100 × 2.1mm, 3µm particle size).
● Column 4: SeQuant ZIC-cHILIC (50 × 2.1mm, 3µm particle size).
Analysis of Streptomycin and Dihydrostreptomycin by LC-MS/MS
using ITSP clean-up and a ZIC-cHILIC HPLC column.
Bruce D. Morris, Derek Yang and Richard B. Schriner.
R.J. Hill Laboratories, Hamilton , New Zealand.
Introduction
LC-MS/MS
References and Acknowledgements
Overview
To meet the Action Limits for both compounds in honey (0.05mg/kg in the UK,
0.02 mg/kg in Germany and Switzerland), an analytical method with an MDL of
0.01 mg/kg or better was required.
Use of LC-MS/MS with HILIC avoids the use of ion-pairing reagents which can
cause significant ESI signal suppression (80% for streptomycin1
).
Both silica-based HILIC and zwitterionic HILIC columns (ZIC-pHILIC and
ZIC-cHILIC, Merck SeQuant) were trialled, the former relying on hydrophilic
partitioning for retention, the latter also providing electrostatic interaction
(Figure 1).
● ZIC-pHILIC – sulfobetaine stationary phase (Figure 2).
● ZIC-cHILIC – phosphorylcholine stationary phase (Figure 2).
Discussion
Method Validation Results
Table 1: ESI-MS/MS parameters.
ESI-MS/MS Parameters
(ESI Positive Polarity)
Compound
Q1
m/z
Q3
(quant)
m/z
Q3 (qual)
m/z
Period
#
Declustering
potential
Streptomycin 582.3 263.2 246.2 2 DP = 200
Dihydrostreptomycin 876.6 263.2 246.2 2 DP = 200
Spectinomycin (SMC) 333.2 112.0 122.0 1 DP = 50
Streptomycin:
● aminoglycoside antibiotic.
● widely used as veterinary medicine for large animals, along with
dihydrostreptomycin.
● used on apple, pear and stonefruit crops to control bacterial diseases.
● used on kiwifruit against Pseudomonas syringae pv. actinidiae (PSA) since its
discovery in New Zealand in 2011, with risk of contamination of honey via bees
used for pollination.
● has been used in beehives against “foulbrood” infections, resulting in a food
scare in the United Kingdom in 2002, when it was detected in Chinese honeys.
1. Gremilogianni, A.M., Megoulas, N.C. and Koupparis, M. A. J. Chromatogr. A 1217 (2010) 6646-51.
2. Yue, D., Hui-yuan, Y., and Wei-dong, X. Acta Metallurgica Sinica, 34 (2009) 669-677.
3. Jiang, W., Appelblad, P., Jonsson, T. and Hemstrom, P. Chromatography Today May/June 2011, pp26-28.
Acknowledgement: SeQuant ZIC-cHILIC were a gift from Dr Wen Jiang, Merck SeQuant AB.
Current Analytical Approaches for Honey:
● ELISA, detection limits range from 0.004 – 0.05mg/kg for streptomycin plus
dihydrestreptomycin, but prone to false positives due to cross-reactions.
● LC-MS/MS on reversed-phase C-18, using ion pairing reagents (e.g. hepta- or
nonafluoropentanoic acid).
● LC-MS/MS on HILIC columns (silica-based or zwitterionic).
2 Dihydrotreptomycin
3 Spectinomycin
Figure 1: Retention mechanisms on ZIC-cHILIC stationary phase.1
Figure 2: ZIC-pHILIC (sulfobetaine) and ZIC-cHILIC
(phosphorylcholine) functional groups.
250µL loaded onto
pre-conditioned CBA
ITSP cartridge
ITSP cartridge
transferred to
instrument vial
Streptomycins eluted
with 150µL 2% formic
acid in water
Rinsed with water to
wash off sugars to
waste
50g/L honey solution
in water
Since streptomycin positives are rare in honey, spectinomycin was used as a
surrogate (SMC), to monitor recovery off the ITSP cartridges for each sample.
● Spectinomycin is more weakly retained, so analyte losses in the rinse step show
up as low recovery of spectinomycin first.
● Initially 0.1M HCl used for elution, however signal suppression was observed
with HCl present
●
Initial experiments showed injections of spiked 50g/L honey solutions gave >150%
recoveries (cf. solvent standards) similar to the enhancement previously observed2
,
possibly due to co-eluting sugars.
●
Therefore a clean-up was developed to remove sugars, using weak cation exchange
ITSP (Instrument Top Sample Preparation), a miniaturized, robotized SPE.
ITSP cartridges.
07-CBA10-20A packed with 10 mg of weak cation exchange (Isolute CBA).
●
Developed by Microliter Analytical Supplies Inc., for use on a CTC Analytics
robotic autosampler.
Gradient A
(Columns 1-3)
Gradient B
(Column 4, 50mm)
Time (min.) %B Flow (mL/min) Time (min.) %B
0.00 90 0.4 0.00 95
0.20 90 0.4 0.20 95
3.70 10 0.4 3.60 10
4.90 10 0.4 4.60 10
5.00 90 0.6 5.10 95
8.00 90 0.6 6.50 95
8.10 90 0.4 6.60 95
Mobile Phases : A = 200mM ammonium formate + 0.5% formic acid in water , B = 0.5%
formic acid in acetonitrile.
Table 2: HPLC column gradients.
ITSP Method Development HPLC Method Development
Table 3: ESI signal suppression by HCl, when using 0.1 M HCl for ITSP elution.
● Elution with 2% formic acid in water avoided HCl.
● Due to precise control of flow rate, ITSP is ideal for cation exchange SPE where too
high a flow rate can result in poor recoveries with bench-top SPE.
Compound (in-vial conc.)
Peak area,
standard, no HCl
Peak area, 0.1M
HCl elution
Signal suppression
Streptomycin (10 µg/L) 2.65 × 104
1.04 × 104
61%
Dihydrostreptomycin (10 µg/L) 5.19 × 104
4.00 × 104
23%
Spectinomycin (SMC, 40 µg/L) 3.04 × 104
1.68 × 104
45%
1 Streptomycin
Figure 3: ITSP cartridges.
Figure 4: ITSP clean-up for streptomycin and dihydrostreptomycin in honey.
Comparison of Columns.
●
Columns 1, 2 and 3 were compared using gradient A (Figures 5-7):
(Figure 5).
Dihydrostreptomycin
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5
Time, min
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
5773
Intensity,cps
Streptomycin
Figure 5: Column 1, Ascentis Express HILIC, gave co-elution of streptomycin
and dihydrostreptomycin, as expected for interaction based solely on
hydrophilic partitioning (25 µg/L in-vial).
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5
Time, min
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2200
2400
2600
2800
3000
3200
Intensity,cps
Dihydrostreptomycin
Streptomycin
Figure 6: Column 2, SeQuant ZIC-pHILIC, gave greater retention than column 1,
and 0.03 min separation of streptomycin and dihydrostreptomycin, indicating
additional electrostatic interactions with the sulfobetaine stationary phase,
likely involving the analytes protonated guinadine and also hydroxyl groups,
(25 µg/L in-vial).
Figure 7: Column 3, SeQuant ZIC-cHILIC, gave similar retention with improved
separation (0.04 min.) over column 2, possibly due to greater interaction of
the δ – charge on the streptomycin aldehyde group with the more exposed
-NH4
+
on the phosphorylcholine stationary phase (25 µg/L in-vial).
H2 added across aldehyde group
gives dihydrostreptomycin
Mobile phase composition.
●
Increasing the concentration of ammonium formate in mobile phase A gave lesser
retention (Figure 8), likely due to ion pairing with the protonated guanidine group.2
●
300mM ammonium formate caused significant signal suppression compared with
200mM.
●
Lower formate (50 and 100 mM) resulted in poor peak shape, and therefore lower
detection limits.
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5
Time, min
0.0
6000.0
8000.0
1.0e4
1.2e4
1.4e4
1.6e4
1.8e4
2.0e4
2.2e4
2.4e4
2.6e4
2.8e4
3.0e4
3.1e4
Intensity,cps
3.95
3.81
4.18
4.38
300mM NH4formate
200mM NH4formate
100mM NH4formate
50mM NH4formate
Figure 8: Effect on varying ammonium formate concentration in mobile phase A
(aqueous), on retention and sensitivity for streptomycin, column 4 (50mm
ZIC-cHILIC), gradient B. Streptomycin = 10 µg/L in-vial.
Mobile phase gradient.
●
Higher percentages of mobile phase B in the initial composition resulted in greater
retention of streptomycin, giving greater ESI sensitivity with elution in mobile
phase with a higher aqueous percentage.
●
Faster gradients gave better peak shapes, with significantly affecting separation of
streptomycin and dihydrostreptomycin, as observed previously for aminoglycoside
antibiotics on ZIC-HILIC columns.3
Use of a ZIC-cHILIC column gave the best separation (0.04 min.) of streptomycin
and dihydrostreptomycin, compared with none on silica-based HILIC, reducing the
overlap of the [M + H + 2]+
ion of streptomycin with the [M + H]+
of
dihydrostreptomycin to 3%.
This means a 0.1mg/kg residue of streptomycin would result in a
dihydrostreptomycin peak less than 1/3 of the MDL, however it would be offset by
0.04 min from the dihydrostreptomycin retention time therefore could be rejected.
Table 4: Method detection limits, precision and recoveries for 0.05 mg/kg spikes of
streptomycin and dihydrostreptomycin on manuka honey (column 4, gradient B).
Compound Mean recovery (n=9)
Standard
deviation
Precision, (RSD)
Streptomycin (1) 104% 0.34µg/kg 3.3%
Dihydrostreptomycin (2) 98% 0.45µg/kg 4.6%
Table 5: Precision and recoveries for 0.5 mg/kg spikes of streptomycin and
dihydrostreptomycin on manuka honey (column 4, gradient B).
●
Spike recoveries for 0.5 and 0.05 mg/kg spike experiments were 98-105%,
showing that the ITSP clean-up was removing honey matrix previously observed to
give signal enhancement.1
●
Method detection limits were ≤ 0.01 mg/kg, lower than the EU Action Limits.
Compound
Mean
recovery
(n=8)
Precision
(%Standard
deviation)
Method
detection limit
(EPA
calculation)a
Method
detection limit
(from S/N)b
Streptomycin (1) 105% 5.9% 0.01 mg/kg 0.005 mg/kg
Dihydrostreptomycin (2) 101% 10.6% 0.01 mg/kg 0.005 mg/kg
a
EPA MDL = standard deviation × Student’s t-distribution value (2.998 for n = 8, 99% 1-sided CI).
B
Signal-to-noise MDL = 3 × concentration /peak-peak signal-to-noise, for a 0.2µg/L standard.
(both MDL results from qualifier MRMs)

More Related Content

What's hot

VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
Manik Ghosh
 
Flexible Automated Sample Prep Workflows
Flexible Automated Sample Prep WorkflowsFlexible Automated Sample Prep Workflows
Flexible Automated Sample Prep Workflows
Shimadzu Scientific Instruments
 
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
pharmaindexing
 
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
SriramNagarajan15
 
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
IOSR Journals
 
Dandruff vs normal corneocytes
Dandruff vs normal corneocytesDandruff vs normal corneocytes
Dandruff vs normal corneocytes
Samares Biswas
 
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassayExpt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
VISHALJADHAV100
 
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
VISHALJADHAV100
 
Determination of Satranidazole through Ion-Associative Complex Reaction
Determination of Satranidazole through Ion-Associative Complex ReactionDetermination of Satranidazole through Ion-Associative Complex Reaction
Determination of Satranidazole through Ion-Associative Complex Reaction
Ratnakaram Venkata Nadh
 
UV spectrophotometric method development and validation for quantitative esti...
UV spectrophotometric method development and validation for quantitative esti...UV spectrophotometric method development and validation for quantitative esti...
UV spectrophotometric method development and validation for quantitative esti...
Sagar Savale
 
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Ratnakaram Venkata Nadh
 
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
SriramNagarajan19
 
Determination of the potency of Paracetamol (Napa) tablet by UV-Spectrophoto...
Determination of the potency of Paracetamol (Napa) tablet  by UV-Spectrophoto...Determination of the potency of Paracetamol (Napa) tablet  by UV-Spectrophoto...
Determination of the potency of Paracetamol (Napa) tablet by UV-Spectrophoto...
Protik Biswas
 
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope AnalysisPicarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
Picarro
 
Validated High-performance Liquid Chromatography Method for Degradation Study...
Validated High-performance Liquid Chromatography Method for Degradation Study...Validated High-performance Liquid Chromatography Method for Degradation Study...
Validated High-performance Liquid Chromatography Method for Degradation Study...
BRNSS Publication Hub
 
Research Inventy : International Journal of Engineering and Science
Research Inventy : International Journal of Engineering and ScienceResearch Inventy : International Journal of Engineering and Science
Research Inventy : International Journal of Engineering and Science
researchinventy
 
Formulation and evaluation of sitagliptan floating tablets
Formulation and evaluation of sitagliptan floating tabletsFormulation and evaluation of sitagliptan floating tablets
Formulation and evaluation of sitagliptan floating tablets
SriramNagarajan19
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
VISHALJADHAV100
 

What's hot (18)

VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...
 
Flexible Automated Sample Prep Workflows
Flexible Automated Sample Prep WorkflowsFlexible Automated Sample Prep Workflows
Flexible Automated Sample Prep Workflows
 
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
 
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
Estimation of Pioglitazone hydrochloride in Bulk and Pharmaceutical dosage fo...
 
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
Analytical Determination of Antihestamine drugs Pure and its pharmaceutical P...
 
Dandruff vs normal corneocytes
Dandruff vs normal corneocytesDandruff vs normal corneocytes
Dandruff vs normal corneocytes
 
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassayExpt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 2 Bioassay of acetylcholine using rat ileum by four point bioassay
 
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
Expt. 8 Effect of physostigmine on DRC of acetylcholine using frog rectus abd...
 
Determination of Satranidazole through Ion-Associative Complex Reaction
Determination of Satranidazole through Ion-Associative Complex ReactionDetermination of Satranidazole through Ion-Associative Complex Reaction
Determination of Satranidazole through Ion-Associative Complex Reaction
 
UV spectrophotometric method development and validation for quantitative esti...
UV spectrophotometric method development and validation for quantitative esti...UV spectrophotometric method development and validation for quantitative esti...
UV spectrophotometric method development and validation for quantitative esti...
 
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
 
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
Synthesis, Characterization and invitro Anti- inflammatory activity of 1, 3, ...
 
Determination of the potency of Paracetamol (Napa) tablet by UV-Spectrophoto...
Determination of the potency of Paracetamol (Napa) tablet  by UV-Spectrophoto...Determination of the potency of Paracetamol (Napa) tablet  by UV-Spectrophoto...
Determination of the potency of Paracetamol (Napa) tablet by UV-Spectrophoto...
 
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope AnalysisPicarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
Picarro Combustion Module Cavity Ring Down Spectroscopy Stable Isotope Analysis
 
Validated High-performance Liquid Chromatography Method for Degradation Study...
Validated High-performance Liquid Chromatography Method for Degradation Study...Validated High-performance Liquid Chromatography Method for Degradation Study...
Validated High-performance Liquid Chromatography Method for Degradation Study...
 
Research Inventy : International Journal of Engineering and Science
Research Inventy : International Journal of Engineering and ScienceResearch Inventy : International Journal of Engineering and Science
Research Inventy : International Journal of Engineering and Science
 
Formulation and evaluation of sitagliptan floating tablets
Formulation and evaluation of sitagliptan floating tabletsFormulation and evaluation of sitagliptan floating tablets
Formulation and evaluation of sitagliptan floating tablets
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
 

Viewers also liked

Cardiovascular Drugs Market in KSA & UAE
Cardiovascular Drugs Market in KSA & UAE Cardiovascular Drugs Market in KSA & UAE
Cardiovascular Drugs Market in KSA & UAE
TanuChopra
 
30.aminoglycosides
30.aminoglycosides30.aminoglycosides
30.aminoglycosides
Dr.Manish Kumar
 
Cardiovascular drugs by maghan das
Cardiovascular drugs by maghan dasCardiovascular drugs by maghan das
Cardiovascular drugs by maghan das
Maghan Das
 
Antibiotic Groups - Aminoglycosides
Antibiotic Groups - AminoglycosidesAntibiotic Groups - Aminoglycosides
Antibiotic Groups - Aminoglycosides
Ossama Motawae
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Mr.S.SEETARAM SWAMY
 
cardiovascular remodeling and it's prevention
cardiovascular remodeling and it's preventioncardiovascular remodeling and it's prevention
cardiovascular remodeling and it's prevention
Dr.Subrata Das
 
Pharmacogenomics in Cardiovascular Diseases
Pharmacogenomics in Cardiovascular DiseasesPharmacogenomics in Cardiovascular Diseases
Pharmacogenomics in Cardiovascular Diseases
arna318
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular systemDina Ghoraba
 
Antibiotics Groups - Phenicoles
Antibiotics Groups - PhenicolesAntibiotics Groups - Phenicoles
Antibiotics Groups - Phenicoles
Ossama Motawae
 
drug used
drug useddrug used
drug used
Mohamad Samir
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Surya Prajapat
 
ocular pharmacology anti viral and anti fungal
ocular pharmacology anti viral and anti fungalocular pharmacology anti viral and anti fungal
ocular pharmacology anti viral and anti fungal
Pratyush Dhakal
 
Cardiovascular drugs
Cardiovascular drugsCardiovascular drugs
Cardiovascular drugs
Oriba Dan Langoya
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside ppt
neetu ojha
 
Anti Viral Drugs in Ophthalmology
Anti Viral Drugs in OphthalmologyAnti Viral Drugs in Ophthalmology
Anti Viral Drugs in Ophthalmology
Ankit Punjabi
 
Anti viral agents
Anti viral agentsAnti viral agents
Anti viral agentsraj kumar
 

Viewers also liked (20)

Cardiovascular Drugs Market in KSA & UAE
Cardiovascular Drugs Market in KSA & UAE Cardiovascular Drugs Market in KSA & UAE
Cardiovascular Drugs Market in KSA & UAE
 
30.aminoglycosides
30.aminoglycosides30.aminoglycosides
30.aminoglycosides
 
Cardiovascular drugs by maghan das
Cardiovascular drugs by maghan dasCardiovascular drugs by maghan das
Cardiovascular drugs by maghan das
 
Antibiotic Groups - Aminoglycosides
Antibiotic Groups - AminoglycosidesAntibiotic Groups - Aminoglycosides
Antibiotic Groups - Aminoglycosides
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
cardiovascular remodeling and it's prevention
cardiovascular remodeling and it's preventioncardiovascular remodeling and it's prevention
cardiovascular remodeling and it's prevention
 
Pharmacogenomics in Cardiovascular Diseases
Pharmacogenomics in Cardiovascular DiseasesPharmacogenomics in Cardiovascular Diseases
Pharmacogenomics in Cardiovascular Diseases
 
Anti Viral
Anti ViralAnti Viral
Anti Viral
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular system
 
Antibiotics Groups - Phenicoles
Antibiotics Groups - PhenicolesAntibiotics Groups - Phenicoles
Antibiotics Groups - Phenicoles
 
Cvs drugs new
Cvs drugs   newCvs drugs   new
Cvs drugs new
 
drug used
drug useddrug used
drug used
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
ocular pharmacology anti viral and anti fungal
ocular pharmacology anti viral and anti fungalocular pharmacology anti viral and anti fungal
ocular pharmacology anti viral and anti fungal
 
Cardiovascular drugs
Cardiovascular drugsCardiovascular drugs
Cardiovascular drugs
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Aminoglycoside ppt
Aminoglycoside pptAminoglycoside ppt
Aminoglycoside ppt
 
Anti Viral Drugs in Ophthalmology
Anti Viral Drugs in OphthalmologyAnti Viral Drugs in Ophthalmology
Anti Viral Drugs in Ophthalmology
 
Anti viral agents
Anti viral agentsAnti viral agents
Anti viral agents
 
14. antiviral drugs
14. antiviral drugs14. antiviral drugs
14. antiviral drugs
 

Similar to Streptomycin in Honey Poster

EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMAConference
 
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA
 
Automated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterAutomated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterRick Youngblood
 
Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Dr. Mukesh Raikwar
 
LC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminantsLC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminants
SCIEX
 
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
PerkinElmer, Inc.
 
Carbohydrate, isolation and purification techniques. A complete view.
Carbohydrate, isolation and purification techniques. A complete view.Carbohydrate, isolation and purification techniques. A complete view.
Carbohydrate, isolation and purification techniques. A complete view.
NEHA MISHRA
 
A Systemic Study of Chitin Digestion Protocols
A Systemic Study of Chitin Digestion ProtocolsA Systemic Study of Chitin Digestion Protocols
A Systemic Study of Chitin Digestion Protocols
Arjuna Karikaran
 
ACENRES-2016-INBRE-Poster-Combined (minor color changes)
ACENRES-2016-INBRE-Poster-Combined (minor color changes)ACENRES-2016-INBRE-Poster-Combined (minor color changes)
ACENRES-2016-INBRE-Poster-Combined (minor color changes)Justin Barrett
 
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONSRP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
IJSIT Editor
 
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassayExpt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
VISHALJADHAV100
 
Simona cavalu apmas2014
Simona cavalu apmas2014Simona cavalu apmas2014
Simona cavalu apmas2014
Simona Cavalu
 
Advances in size exclusion chromatography for the analysis of small proteins ...
Advances in size exclusion chromatography for the analysis of small proteins ...Advances in size exclusion chromatography for the analysis of small proteins ...
Advances in size exclusion chromatography for the analysis of small proteins ...
Eduardo Castro
 
ELISA results interpretation [Autosaved].pptx
ELISA results interpretation [Autosaved].pptxELISA results interpretation [Autosaved].pptx
ELISA results interpretation [Autosaved].pptx
AmirRaziq1
 
Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...
BRNSS Publication Hub
 
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
pharmaindexing
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...Qing Chen
 
Mathematical modelling and analysis of the mushroom drying process at the opt...
Mathematical modelling and analysis of the mushroom drying process at the opt...Mathematical modelling and analysis of the mushroom drying process at the opt...
Mathematical modelling and analysis of the mushroom drying process at the opt...
IJERA Editor
 
Pharmaceutical Sci Flashcards _ Quizlet.pdf
Pharmaceutical Sci Flashcards _ Quizlet.pdfPharmaceutical Sci Flashcards _ Quizlet.pdf
Pharmaceutical Sci Flashcards _ Quizlet.pdf
rakydt
 

Similar to Streptomycin in Honey Poster (20)

EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
 
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
EWMA 2013 - Ep473 -A new anti-biofilm dressing Demonstration of enhanced silv...
 
Automated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling PosterAutomated SPE for Capillary Microsampling Poster
Automated SPE for Capillary Microsampling Poster
 
Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...Method Development and Validation of Tetracycline Antibiotics and their Epime...
Method Development and Validation of Tetracycline Antibiotics and their Epime...
 
LC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminantsLC-MS/MS analysis of emerging food contaminants
LC-MS/MS analysis of emerging food contaminants
 
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
Analysis of Phenolic Antioxidants in Edible Oil/Shortening Using the PerkinEl...
 
Carbohydrate, isolation and purification techniques. A complete view.
Carbohydrate, isolation and purification techniques. A complete view.Carbohydrate, isolation and purification techniques. A complete view.
Carbohydrate, isolation and purification techniques. A complete view.
 
A Systemic Study of Chitin Digestion Protocols
A Systemic Study of Chitin Digestion ProtocolsA Systemic Study of Chitin Digestion Protocols
A Systemic Study of Chitin Digestion Protocols
 
ACENRES-2016-INBRE-Poster-Combined (minor color changes)
ACENRES-2016-INBRE-Poster-Combined (minor color changes)ACENRES-2016-INBRE-Poster-Combined (minor color changes)
ACENRES-2016-INBRE-Poster-Combined (minor color changes)
 
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONSRP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
RP-HPLC METHOD FOR THE QUANTIFICATION OF OXALIPLATIN IN FORMULATIONS
 
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassayExpt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
Expt. 7 Bioassay of acetylcholine using rat ileum by four point bioassay
 
Simona cavalu apmas2014
Simona cavalu apmas2014Simona cavalu apmas2014
Simona cavalu apmas2014
 
Advances in size exclusion chromatography for the analysis of small proteins ...
Advances in size exclusion chromatography for the analysis of small proteins ...Advances in size exclusion chromatography for the analysis of small proteins ...
Advances in size exclusion chromatography for the analysis of small proteins ...
 
PDF Article Filtration
PDF Article FiltrationPDF Article Filtration
PDF Article Filtration
 
ELISA results interpretation [Autosaved].pptx
ELISA results interpretation [Autosaved].pptxELISA results interpretation [Autosaved].pptx
ELISA results interpretation [Autosaved].pptx
 
Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...Application of Validated High-performance Liquid Chromatography Method for De...
Application of Validated High-performance Liquid Chromatography Method for De...
 
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
Development and Validation of RP – HPLC Method for the estimation of Oxycloza...
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
 
Mathematical modelling and analysis of the mushroom drying process at the opt...
Mathematical modelling and analysis of the mushroom drying process at the opt...Mathematical modelling and analysis of the mushroom drying process at the opt...
Mathematical modelling and analysis of the mushroom drying process at the opt...
 
Pharmaceutical Sci Flashcards _ Quizlet.pdf
Pharmaceutical Sci Flashcards _ Quizlet.pdfPharmaceutical Sci Flashcards _ Quizlet.pdf
Pharmaceutical Sci Flashcards _ Quizlet.pdf
 

More from Rick Youngblood

Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...
Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...
Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...Rick Youngblood
 
ITSP PAL Training - Intermediate
ITSP PAL Training - IntermediateITSP PAL Training - Intermediate
ITSP PAL Training - Intermediate
Rick Youngblood
 
ITSP PAL Training - Advanced
ITSP PAL Training - AdvancedITSP PAL Training - Advanced
ITSP PAL Training - AdvancedRick Youngblood
 
ITSP PAL Training - Basic
ITSP PAL Training - BasicITSP PAL Training - Basic
ITSP PAL Training - BasicRick Youngblood
 
Optimization of Automated Online SPE-LC-MS
Optimization of Automated Online SPE-LC-MSOptimization of Automated Online SPE-LC-MS
Optimization of Automated Online SPE-LC-MSRick Youngblood
 
Unified-Drug-Analysis-PittCon-2016
Unified-Drug-Analysis-PittCon-2016Unified-Drug-Analysis-PittCon-2016
Unified-Drug-Analysis-PittCon-2016Rick Youngblood
 
Barbiturates and THCA in Urine at OpAns
Barbiturates and THCA in Urine at OpAnsBarbiturates and THCA in Urine at OpAns
Barbiturates and THCA in Urine at OpAnsRick Youngblood
 
Androstenedione and Testosterone in Serum
Androstenedione and Testosterone in SerumAndrostenedione and Testosterone in Serum
Androstenedione and Testosterone in SerumRick Youngblood
 
Drugs of Abuse in Post Mortem Blood Poster
Drugs of Abuse in Post Mortem Blood PosterDrugs of Abuse in Post Mortem Blood Poster
Drugs of Abuse in Post Mortem Blood PosterRick Youngblood
 
Manual Single Cartridge Holder Flyer
Manual Single Cartridge Holder FlyerManual Single Cartridge Holder Flyer
Manual Single Cartridge Holder FlyerRick Youngblood
 
QuEChERS Pittcon 2014 Poster
QuEChERS Pittcon 2014 PosterQuEChERS Pittcon 2014 Poster
QuEChERS Pittcon 2014 PosterRick Youngblood
 
Drugs_of_Abuse_Application_Note
Drugs_of_Abuse_Application_NoteDrugs_of_Abuse_Application_Note
Drugs_of_Abuse_Application_NoteRick Youngblood
 
Go Green Brochure-MicroLiter
Go Green Brochure-MicroLiterGo Green Brochure-MicroLiter
Go Green Brochure-MicroLiterRick Youngblood
 

More from Rick Youngblood (20)

Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...
Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...
Automated Chromatographic Solid-Phase Extraction Using an Autosampler _ Ameri...
 
ITSP PAL Training - Intermediate
ITSP PAL Training - IntermediateITSP PAL Training - Intermediate
ITSP PAL Training - Intermediate
 
ITSP PAL Training - Advanced
ITSP PAL Training - AdvancedITSP PAL Training - Advanced
ITSP PAL Training - Advanced
 
ITSP PAL Training - Basic
ITSP PAL Training - BasicITSP PAL Training - Basic
ITSP PAL Training - Basic
 
ITSP Dual Rail Project
ITSP Dual Rail ProjectITSP Dual Rail Project
ITSP Dual Rail Project
 
ITSP New Stuff
ITSP New StuffITSP New Stuff
ITSP New Stuff
 
Nova Analytica
Nova AnalyticaNova Analytica
Nova Analytica
 
Optimization of Automated Online SPE-LC-MS
Optimization of Automated Online SPE-LC-MSOptimization of Automated Online SPE-LC-MS
Optimization of Automated Online SPE-LC-MS
 
Unified-Drug-Analysis-PittCon-2016
Unified-Drug-Analysis-PittCon-2016Unified-Drug-Analysis-PittCon-2016
Unified-Drug-Analysis-PittCon-2016
 
ITSP Setup on PAL-xt
ITSP Setup on PAL-xtITSP Setup on PAL-xt
ITSP Setup on PAL-xt
 
ITSP Introduction
ITSP IntroductionITSP Introduction
ITSP Introduction
 
Barbiturates and THCA in Urine at OpAns
Barbiturates and THCA in Urine at OpAnsBarbiturates and THCA in Urine at OpAns
Barbiturates and THCA in Urine at OpAns
 
DUI-D in Urine Poster
DUI-D in Urine PosterDUI-D in Urine Poster
DUI-D in Urine Poster
 
Androstenedione and Testosterone in Serum
Androstenedione and Testosterone in SerumAndrostenedione and Testosterone in Serum
Androstenedione and Testosterone in Serum
 
Drugs of Abuse in Post Mortem Blood Poster
Drugs of Abuse in Post Mortem Blood PosterDrugs of Abuse in Post Mortem Blood Poster
Drugs of Abuse in Post Mortem Blood Poster
 
Manual Single Cartridge Holder Flyer
Manual Single Cartridge Holder FlyerManual Single Cartridge Holder Flyer
Manual Single Cartridge Holder Flyer
 
as119
as119as119
as119
 
QuEChERS Pittcon 2014 Poster
QuEChERS Pittcon 2014 PosterQuEChERS Pittcon 2014 Poster
QuEChERS Pittcon 2014 Poster
 
Drugs_of_Abuse_Application_Note
Drugs_of_Abuse_Application_NoteDrugs_of_Abuse_Application_Note
Drugs_of_Abuse_Application_Note
 
Go Green Brochure-MicroLiter
Go Green Brochure-MicroLiterGo Green Brochure-MicroLiter
Go Green Brochure-MicroLiter
 

Streptomycin in Honey Poster

  • 1. 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 Time, min 0.0 1000.0 2000.0 3000.0 4000.0 5000.0 6000.0 7000.0 8000.0 9000.0 1.0e4 1.1e4 1.2e4 1.3e4 1.4e4 1.5e4 1.6e4 Intensity,cps Dihydrostreptomycin Streptomycin ● Instrument : AB Sciex 3200 QQQ. ● ESI Parameters: TEM = 400, IS = 3000, compound specific parameters in Table 1. ● Injection volume = 30 µL. ● HPLC Columns: ● Column 1: Ascentis Express HILIC (100 × 2.1mm, 2.7µm particle size). ● Column 2: SeQuant ZIC-pHILIC (150 × 2.1mm, 5µm particle size). ● Column 3: SeQuant ZIC-cHILIC (100 × 2.1mm, 3µm particle size). ● Column 4: SeQuant ZIC-cHILIC (50 × 2.1mm, 3µm particle size). Analysis of Streptomycin and Dihydrostreptomycin by LC-MS/MS using ITSP clean-up and a ZIC-cHILIC HPLC column. Bruce D. Morris, Derek Yang and Richard B. Schriner. R.J. Hill Laboratories, Hamilton , New Zealand. Introduction LC-MS/MS References and Acknowledgements Overview To meet the Action Limits for both compounds in honey (0.05mg/kg in the UK, 0.02 mg/kg in Germany and Switzerland), an analytical method with an MDL of 0.01 mg/kg or better was required. Use of LC-MS/MS with HILIC avoids the use of ion-pairing reagents which can cause significant ESI signal suppression (80% for streptomycin1 ). Both silica-based HILIC and zwitterionic HILIC columns (ZIC-pHILIC and ZIC-cHILIC, Merck SeQuant) were trialled, the former relying on hydrophilic partitioning for retention, the latter also providing electrostatic interaction (Figure 1). ● ZIC-pHILIC – sulfobetaine stationary phase (Figure 2). ● ZIC-cHILIC – phosphorylcholine stationary phase (Figure 2). Discussion Method Validation Results Table 1: ESI-MS/MS parameters. ESI-MS/MS Parameters (ESI Positive Polarity) Compound Q1 m/z Q3 (quant) m/z Q3 (qual) m/z Period # Declustering potential Streptomycin 582.3 263.2 246.2 2 DP = 200 Dihydrostreptomycin 876.6 263.2 246.2 2 DP = 200 Spectinomycin (SMC) 333.2 112.0 122.0 1 DP = 50 Streptomycin: ● aminoglycoside antibiotic. ● widely used as veterinary medicine for large animals, along with dihydrostreptomycin. ● used on apple, pear and stonefruit crops to control bacterial diseases. ● used on kiwifruit against Pseudomonas syringae pv. actinidiae (PSA) since its discovery in New Zealand in 2011, with risk of contamination of honey via bees used for pollination. ● has been used in beehives against “foulbrood” infections, resulting in a food scare in the United Kingdom in 2002, when it was detected in Chinese honeys. 1. Gremilogianni, A.M., Megoulas, N.C. and Koupparis, M. A. J. Chromatogr. A 1217 (2010) 6646-51. 2. Yue, D., Hui-yuan, Y., and Wei-dong, X. Acta Metallurgica Sinica, 34 (2009) 669-677. 3. Jiang, W., Appelblad, P., Jonsson, T. and Hemstrom, P. Chromatography Today May/June 2011, pp26-28. Acknowledgement: SeQuant ZIC-cHILIC were a gift from Dr Wen Jiang, Merck SeQuant AB. Current Analytical Approaches for Honey: ● ELISA, detection limits range from 0.004 – 0.05mg/kg for streptomycin plus dihydrestreptomycin, but prone to false positives due to cross-reactions. ● LC-MS/MS on reversed-phase C-18, using ion pairing reagents (e.g. hepta- or nonafluoropentanoic acid). ● LC-MS/MS on HILIC columns (silica-based or zwitterionic). 2 Dihydrotreptomycin 3 Spectinomycin Figure 1: Retention mechanisms on ZIC-cHILIC stationary phase.1 Figure 2: ZIC-pHILIC (sulfobetaine) and ZIC-cHILIC (phosphorylcholine) functional groups. 250µL loaded onto pre-conditioned CBA ITSP cartridge ITSP cartridge transferred to instrument vial Streptomycins eluted with 150µL 2% formic acid in water Rinsed with water to wash off sugars to waste 50g/L honey solution in water Since streptomycin positives are rare in honey, spectinomycin was used as a surrogate (SMC), to monitor recovery off the ITSP cartridges for each sample. ● Spectinomycin is more weakly retained, so analyte losses in the rinse step show up as low recovery of spectinomycin first. ● Initially 0.1M HCl used for elution, however signal suppression was observed with HCl present ● Initial experiments showed injections of spiked 50g/L honey solutions gave >150% recoveries (cf. solvent standards) similar to the enhancement previously observed2 , possibly due to co-eluting sugars. ● Therefore a clean-up was developed to remove sugars, using weak cation exchange ITSP (Instrument Top Sample Preparation), a miniaturized, robotized SPE. ITSP cartridges. 07-CBA10-20A packed with 10 mg of weak cation exchange (Isolute CBA). ● Developed by Microliter Analytical Supplies Inc., for use on a CTC Analytics robotic autosampler. Gradient A (Columns 1-3) Gradient B (Column 4, 50mm) Time (min.) %B Flow (mL/min) Time (min.) %B 0.00 90 0.4 0.00 95 0.20 90 0.4 0.20 95 3.70 10 0.4 3.60 10 4.90 10 0.4 4.60 10 5.00 90 0.6 5.10 95 8.00 90 0.6 6.50 95 8.10 90 0.4 6.60 95 Mobile Phases : A = 200mM ammonium formate + 0.5% formic acid in water , B = 0.5% formic acid in acetonitrile. Table 2: HPLC column gradients. ITSP Method Development HPLC Method Development Table 3: ESI signal suppression by HCl, when using 0.1 M HCl for ITSP elution. ● Elution with 2% formic acid in water avoided HCl. ● Due to precise control of flow rate, ITSP is ideal for cation exchange SPE where too high a flow rate can result in poor recoveries with bench-top SPE. Compound (in-vial conc.) Peak area, standard, no HCl Peak area, 0.1M HCl elution Signal suppression Streptomycin (10 µg/L) 2.65 × 104 1.04 × 104 61% Dihydrostreptomycin (10 µg/L) 5.19 × 104 4.00 × 104 23% Spectinomycin (SMC, 40 µg/L) 3.04 × 104 1.68 × 104 45% 1 Streptomycin Figure 3: ITSP cartridges. Figure 4: ITSP clean-up for streptomycin and dihydrostreptomycin in honey. Comparison of Columns. ● Columns 1, 2 and 3 were compared using gradient A (Figures 5-7): (Figure 5). Dihydrostreptomycin 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 Time, min 0 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 5500 5773 Intensity,cps Streptomycin Figure 5: Column 1, Ascentis Express HILIC, gave co-elution of streptomycin and dihydrostreptomycin, as expected for interaction based solely on hydrophilic partitioning (25 µg/L in-vial). 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 Time, min 0 200 400 600 800 1000 1200 1400 1600 1800 2000 2200 2400 2600 2800 3000 3200 Intensity,cps Dihydrostreptomycin Streptomycin Figure 6: Column 2, SeQuant ZIC-pHILIC, gave greater retention than column 1, and 0.03 min separation of streptomycin and dihydrostreptomycin, indicating additional electrostatic interactions with the sulfobetaine stationary phase, likely involving the analytes protonated guinadine and also hydroxyl groups, (25 µg/L in-vial). Figure 7: Column 3, SeQuant ZIC-cHILIC, gave similar retention with improved separation (0.04 min.) over column 2, possibly due to greater interaction of the δ – charge on the streptomycin aldehyde group with the more exposed -NH4 + on the phosphorylcholine stationary phase (25 µg/L in-vial). H2 added across aldehyde group gives dihydrostreptomycin Mobile phase composition. ● Increasing the concentration of ammonium formate in mobile phase A gave lesser retention (Figure 8), likely due to ion pairing with the protonated guanidine group.2 ● 300mM ammonium formate caused significant signal suppression compared with 200mM. ● Lower formate (50 and 100 mM) resulted in poor peak shape, and therefore lower detection limits. 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 Time, min 0.0 6000.0 8000.0 1.0e4 1.2e4 1.4e4 1.6e4 1.8e4 2.0e4 2.2e4 2.4e4 2.6e4 2.8e4 3.0e4 3.1e4 Intensity,cps 3.95 3.81 4.18 4.38 300mM NH4formate 200mM NH4formate 100mM NH4formate 50mM NH4formate Figure 8: Effect on varying ammonium formate concentration in mobile phase A (aqueous), on retention and sensitivity for streptomycin, column 4 (50mm ZIC-cHILIC), gradient B. Streptomycin = 10 µg/L in-vial. Mobile phase gradient. ● Higher percentages of mobile phase B in the initial composition resulted in greater retention of streptomycin, giving greater ESI sensitivity with elution in mobile phase with a higher aqueous percentage. ● Faster gradients gave better peak shapes, with significantly affecting separation of streptomycin and dihydrostreptomycin, as observed previously for aminoglycoside antibiotics on ZIC-HILIC columns.3 Use of a ZIC-cHILIC column gave the best separation (0.04 min.) of streptomycin and dihydrostreptomycin, compared with none on silica-based HILIC, reducing the overlap of the [M + H + 2]+ ion of streptomycin with the [M + H]+ of dihydrostreptomycin to 3%. This means a 0.1mg/kg residue of streptomycin would result in a dihydrostreptomycin peak less than 1/3 of the MDL, however it would be offset by 0.04 min from the dihydrostreptomycin retention time therefore could be rejected. Table 4: Method detection limits, precision and recoveries for 0.05 mg/kg spikes of streptomycin and dihydrostreptomycin on manuka honey (column 4, gradient B). Compound Mean recovery (n=9) Standard deviation Precision, (RSD) Streptomycin (1) 104% 0.34µg/kg 3.3% Dihydrostreptomycin (2) 98% 0.45µg/kg 4.6% Table 5: Precision and recoveries for 0.5 mg/kg spikes of streptomycin and dihydrostreptomycin on manuka honey (column 4, gradient B). ● Spike recoveries for 0.5 and 0.05 mg/kg spike experiments were 98-105%, showing that the ITSP clean-up was removing honey matrix previously observed to give signal enhancement.1 ● Method detection limits were ≤ 0.01 mg/kg, lower than the EU Action Limits. Compound Mean recovery (n=8) Precision (%Standard deviation) Method detection limit (EPA calculation)a Method detection limit (from S/N)b Streptomycin (1) 105% 5.9% 0.01 mg/kg 0.005 mg/kg Dihydrostreptomycin (2) 101% 10.6% 0.01 mg/kg 0.005 mg/kg a EPA MDL = standard deviation × Student’s t-distribution value (2.998 for n = 8, 99% 1-sided CI). B Signal-to-noise MDL = 3 × concentration /peak-peak signal-to-noise, for a 0.2µg/L standard. (both MDL results from qualifier MRMs)